1A9bnbK
1A9bnbK
1A9bnbK
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
***<br />
THE DISEASES − CHAPTER 4<br />
155<br />
Investment targets for in preventive chemotherapy against schistosomiasis<br />
(delivery excluding medicines), 2015–2030<br />
80<br />
Constant US$ millions<br />
60<br />
40<br />
20<br />
●<br />
0<br />
2015<br />
2020<br />
Year<br />
2025<br />
2030<br />
Notes: Shaded areas reflect the range determined by low and high values of the unit cost benchmarks; they do<br />
not reflect uncertainty about future rates of scale-up and scale-down of interventions. The dots in 2012 are actual<br />
numbers reported (when available) multiplied by the unit cost benchmarks; these are not actual expenditures, but<br />
can be thought of as a benchmark for actual expenditures. All numbers expressed in US$ are constant (real) US$,<br />
adjusted to reflect purchasing power in the United States of America in 2015.<br />
can be reduced. The investment target for preventive chemotherapy (delivery excluding<br />
medicines) during 2015–2020 is about US$ 59 million (US$ 51–67 million) per year. The<br />
investment target falls to US$ 55 million (US$ 47–64 million) per year during 2021–2030,<br />
or US$ 31 million (US$ 27–36 million) by 2030.<br />
As work continues on the third edition of the Disease Control Priorities Project, WHO is<br />
working also on an analysis of the cost-effectiveness of integrated preventive chemotherapy<br />
for helminth elimination and control.<br />
_____________________<br />
1<br />
Ugbomoiko US, Ofoezie IE, Okoye IC, Heukelbach J. Factors associated with urinary schistosomiasis<br />
in two peri-urban communities in south-western Nigeria. Ann Trop Med Parasitol. 2010;104:409–19.<br />
doi:10.1179/136485910x12743554760469.<br />
2<br />
Ugbomoiko US, Dalumo V, Danladi YK, Heukelbach J, Ofoezie IE. Concurrent urinary and intestinal schistosomiasis<br />
and intestinal helminthic infections in schoolchildren in Ilobu, South-western Nigeria. Acta Trop. 2012;123:16–21.<br />
doi:10.1016/j.actatropica.2012.03.002.<br />
3<br />
Ndeffo Mbah ML, Poolman EM, Atkins KE, Orenstein EW, Meyers LA, Townsend JP et al. Potential cost-effectiveness of<br />
schistosomiasis treatment for reducing HIV transmission in Africa – the case of Zimbabwean women. PLoS Negl Trop<br />
Dis. 2013;7:e2346. doi:10.1371/journal.pntd.0002346.
Change language